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Introduction Methods 
Results 
Conclusions 
Trans-catheter aortic valve implantation (TAVI) is a 
treatment for patients with symptomatic aortic 
stenosis, who are high risk or inoperable for 
conventional surgical aortic valve replacement. A 
dynamic interventional X-ray imaging system is 
used to visualize treatment in real time.  The 
resulting patient radiation dose is amongst the 
highest from medical imaging procedures1, and 
operator doses are the highest of all interventional 
cardiac procedures2.  The X-ray system must 
minimise radiation dose whilst maintaining 
adequate image quality for the clinical task, as per 
the ALARP principle3.   
 
Modern interventional X-ray equipment employs 
image processing to permit such a reduction in 
radiation dose.  The aim of this study was to 
investigate whether our recently-installed system 
(AlluraClarity, Philips Healthcare) which contains 
advanced real-time image noise reduction 
algorithms and anatomy-specific X-ray 
optimization, affected patient procedure dose and 
fluoroscopy duration in routine TAVI procedures.    
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Total procedure dose medians were 4016 and 7088 cGy cm2 
from the AlluraClarity and reference systems respectively.  
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contributions are shown in figures below with fluoroscopy 
duration. All differences in patient dose were significant at 
the 5% level.   
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The AlluraClarity cardiac catheter lab had 43% lower 
total patient procedure dose for TAVI patients than 
the reference lab.  Fluoroscopy and digital image 
acquisition doses were 31% and 69% lower 
respectively, with no statistically significant difference 
in fluoroscopy duration between the two labs.   
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Procedures dose for 42 TAVI patients from the AlluraClarity 
cardiac catheter lab and from a reference system (Axiom 
Artis, Siemens Healthcare) in the same cardiology 
department was recorded. Median values from the two X-ray 
systems were compared using the Wilcoxon statistical test.  
 
 
Figures: red line is median, blue box is first and third quartiles, 
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